NASDAQ$ATLX
Atlas Lithium Corporation · Q2 2025 earnings
Q2 2025 earnings · · Before market open · Investor relations
Briefing
Atlas Lithium reported Q2 2025 revenue of $31.8M, a net loss of $6.3M, diluted EPS of $-0.31.
For Q2 2025, Atlas Lithium reported Revenue was $31.8M, net loss was $6.3M, diluted EPS was $-0.31. Management discusses segment trends, liquidity, and outlook in the quarterly filing.
- Revenue $31.8M for Q2 2025.
- Net loss $6.3M.
- Diluted EPS $-0.31.
Headline financials
Revenue & EPS history
Atlas Lithium · Revenue · Quarterly
$31.8K
Forward guidance
Healthcare and technology outlook emphasizes pipeline, adoption, and R&D investment.
Tailwinds
- Franchise product growth and launches.
- Cash runway for clinical and commercial programs.
Headwinds
- Reimbursement, competition, and trial risk.
- R&D spend pressuring near-term margins.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q2 2025
-0.7%
Avg return
Earnings day
+6.2%
Avg return
5 days after
+89.2%
Avg return
30 days after
18%
7 / 40 earnings
Positive
+30.5%
Q2 2025
Best reaction
-29.4%
Q2 2017
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +5.5% | +6.8% | -37.1% | |
| Q4 2025 | +1.0% | +8.0% | -6.8% | |
| Q3 2025 | +3.1% | +27.7% | -0.2% | |
| Q2 2025 | +30.5% | +33.6% | +14.5% | |
| Q1 2025 | -2.4% | -6.8% | -4.0% | |
| Q4 2024 | +2.1% | -20.5% | -16.8% | |
| Q3 2024 | -8.0% | -8.7% | -10.3% | |
| Q2 2024 | -8.4% | -8.9% | +0.7% | |
| Q1 2024 | -4.4% | +12.0% | -35.5% | |
| Q4 2023 | +22.3% | +38.6% | +5.4% | |
| Q3 2023 | -27.0% | -19.2% | -12.5% | |
| Q2 2023 | -7.3% | -11.7% | -8.5% | |
| Q1 2023 | -5.9% | -5.7% | +93.1% | |
| Q4 2022 | -0.8% | +1.4% | +97.9% | |
| Q3 2022 | +6.3% | +25.0% | -25.0% | |
| Q2 2022 | +0.0% | +0.0% | +9.1% | |
| Q1 2022 | +0.0% | +0.0% | -12.5% | |
| Q4 2021 | +0.0% | +0.0% | -12.5% | |
| Q3 2021 | +0.0% | +0.0% | -11.1% | |
| Q2 2021 | +0.0% | +0.0% | -16.7% | |
| Q1 2021 | +0.0% | +5.9% | +5.9% | |
| Q4 2020 | +0.0% | +100.0% | +3100.0% | |
| Q3 2020 | +0.0% | +0.0% | +0.0% | |
| Q2 2020 | +0.0% | +0.0% | +0.0% | |
| Q1 2020 | +0.0% | -50.0% | -50.0% | |
| Q4 2019 | +0.0% | +0.0% | -50.0% | |
| Q3 2019 | +0.0% | -25.0% | -25.0% | |
| Q2 2019 | +0.0% | +100.0% | +700.0% | |
| Q1 2019 | +0.0% | +0.0% | +0.0% | |
| Q4 2018 | +0.0% | +0.0% | +0.0% | |
| Q3 2018 | +0.0% | +0.0% | +0.0% | |
| Q2 2018 | +0.0% | +0.0% | +0.0% | |
| Q1 2018 | +0.0% | +0.0% | -33.3% | |
| Q4 2017 | +0.0% | +25.0% | +0.0% | |
| Q3 2017 | +0.0% | +0.0% | -12.5% | |
| Q2 2017 | -29.4% | -35.3% | -70.6% | |
| Q1 2017 | -6.3% | +56.3% | +87.5% | |
| Q4 2016 | +0.0% | +0.0% | -96.8% | |
| Q3 2016 | +0.0% | +0.0% | +0.0% | |
| Q2 2016 | +0.0% | +0.0% | +0.0% | |
| Q1 2016 | — | — | — | |
| Q4 2015 | — | — | — | |
| Q3 2015 | — | — | — | |
| Q2 2015 | — | — | — | |
| Q4 2014 | — | — | — | |
| Q1 2015 | — | — | — | |
| Q3 2014 | — | — | — | |
| Q2 2014 | — | — | — | |
| Q1 2014 | — | — | — | |
| Q4 2013 | — | — | — | |
| Q3 2012 | — | — | — | |
| Q2 2013 | — | — | — | |
| Q1 2013 | — | — | — | |
| Q1 2012 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro